These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
574 related items for PubMed ID: 20645414
21. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat. Stohl W, Gonatas NK. J Immunol; 1978 Sep; 121(3):844-50. PubMed ID: 308523 [Abstract] [Full Text] [Related]
22. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Lyons JA, Ramsbottom MJ, Cross AH. Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610 [Abstract] [Full Text] [Related]
23. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. Johns TG, Kerlero de Rosbo N, Menon KK, Abo S, Gonzales MF, Bernard CC. J Immunol; 1995 May 15; 154(10):5536-41. PubMed ID: 7537310 [Abstract] [Full Text] [Related]
24. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. Chan J, Ban EJ, Chun KH, Wang S, McQualter J, Bernard C, Toh BH, Alderuccio F. Autoimmunity; 2008 Aug 15; 41(5):405-13. PubMed ID: 18568646 [Abstract] [Full Text] [Related]
25. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. Hjelmström P, Juedes AE, Fjell J, Ruddle NH. J Immunol; 1998 Nov 01; 161(9):4480-3. PubMed ID: 9794370 [Abstract] [Full Text] [Related]
26. Chronic neurologic dysfunction and demyelination induced in Lewis rats by repeated injections of encephalitogenic T-lymphocyte lines. Vandenbark AA, Nilaver G, Konat G, Teal P, Offner H. J Neurosci Res; 1986 Nov 01; 16(4):643-56. PubMed ID: 2432277 [Abstract] [Full Text] [Related]
27. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. Ichikawa M, Johns TG, Liu J, Bernard CC. J Immunol; 1996 Jul 15; 157(2):919-26. PubMed ID: 8752946 [Abstract] [Full Text] [Related]
28. Widespread cortical demyelination of both hemispheres can be induced by injection of pro-inflammatory cytokines via an implanted catheter in the cortex of MOG-immunized rats. Üçal M, Haindl MT, Adzemovic MZ, Strasser J, Theisl L, Zeitelhofer M, Kraitsy K, Ropele S, Schäfer U, Fazekas F, Hochmeister S. Exp Neurol; 2017 Aug 15; 294():32-44. PubMed ID: 28457906 [Abstract] [Full Text] [Related]
29. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking. Göbel K, Pankratz S, Schneider-Hohendorf T, Bittner S, Schuhmann MK, Langer HF, Stoll G, Wiendl H, Kleinschnitz C, Meuth SG. J Autoimmun; 2011 Mar 15; 36(2):106-14. PubMed ID: 21216565 [Abstract] [Full Text] [Related]
30. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis. Recks MS, Stormanns ER, Bader J, Arnhold S, Addicks K, Kuerten S. Clin Immunol; 2013 Oct 15; 149(1):32-45. PubMed ID: 23899992 [Abstract] [Full Text] [Related]
31. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. Brown DA, Sawchenko PE. J Comp Neurol; 2007 May 10; 502(2):236-60. PubMed ID: 17348011 [Abstract] [Full Text] [Related]
32. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier. Linker RA, Lühder F, Kallen KJ, Lee DH, Engelhardt B, Rose-John S, Gold R. J Neuroimmunol; 2008 Dec 15; 205(1-2):64-72. PubMed ID: 18950871 [Abstract] [Full Text] [Related]
33. Central nervous system and non-central nervous system antigen vaccines exacerbate neuropathology caused by nerve injury. Ankeny DP, Popovich PG. Eur J Neurosci; 2007 Apr 15; 25(7):2053-64. PubMed ID: 17439492 [Abstract] [Full Text] [Related]
34. Characterization of the encephalitogenic immune response in a model of multiple sclerosis. de Graaf KL, Barth S, Herrmann MM, Storch MK, Wiesmüller KH, Weissert R. Eur J Immunol; 2008 Jan 15; 38(1):299-308. PubMed ID: 18050272 [Abstract] [Full Text] [Related]
35. Induction of progressive demyelinating autoimmune encephalomyelitis in common marmoset monkeys using MOG34-56 peptide in incomplete freund adjuvant. Jagessar SA, Kap YS, Heijmans N, van Driel N, van Straalen L, Bajramovic JJ, Brok HP, Blezer EL, Bauer J, Laman JD, 't Hart BA. J Neuropathol Exp Neurol; 2010 Apr 15; 69(4):372-85. PubMed ID: 20448482 [Abstract] [Full Text] [Related]
36. Adapted focal experimental autoimmune encephalomyelitis to allow MRI exploration of multiple sclerosis features. Tourdias T, Hiba B, Raffard G, Biran M, Nishiguchi T, Aussudre J, Franconi JM, Brochet B, Petry KG, Dousset V. Exp Neurol; 2011 Aug 15; 230(2):248-57. PubMed ID: 21575634 [Abstract] [Full Text] [Related]
37. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE. Skundric DS, Dai R, Zakarian VL, Bessert D, Skoff RP, Cruikshank WW, Kurjakovic Z. J Neurosci Res; 2005 Mar 01; 79(5):680-93. PubMed ID: 15682385 [Abstract] [Full Text] [Related]
38. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2. Jung S, Toyka K, Hartung HP. Eur J Immunol; 1995 May 01; 25(5):1391-8. PubMed ID: 7539758 [Abstract] [Full Text] [Related]
39. Cross-reactivity between human cytomegalovirus peptide 981-1003 and myelin oligodendroglia glycoprotein peptide 35-55 in experimental autoimmune encephalomyelitis in Lewis rats. Zheng MM, Zhang XH. Biochem Biophys Res Commun; 2014 Jan 17; 443(3):1118-23. PubMed ID: 24388990 [Abstract] [Full Text] [Related]
40. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis. Blaževski J, Petković F, Momčilović M, Jevtic B, Miljković D, Mostarica Stojković M. Immunobiology; 2013 Sep 17; 218(9):1192-9. PubMed ID: 23664544 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]